White Matter and Neuroprotection in Alzheimer’s Dementia
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Myelin is the main component of the white matter of the central nervous system (CNS), allowing the proper electrical function of the neurons by ensheathing and insulating the axons. The extensive use of magnetic resonance imaging has highlighted the white matter alterations in Alzheimer’s dementia (AD) and other neurodegenerative diseases, alterations which are early, extended, and regionally selective. Given that the white matter turnover is considerable in the adulthood, and that myelin repair is currently recognized as being the only true reparative capability of the mature CNS, oligodendrocyte precursor cells (OPCs), the cells that differentiate in oligodendrocyte, responsible for myelin formation and repair, are regarded as a potential target for neuroprotection. In this review, several aspects of the OPC biology are reviewed. The histology and functional role of OPCs in the neurovascular-neuroglial unit as described in preclinical and clinical studies on AD is discussed, such as the OPC vulnerability to hypoxia-ischemia, neuroinflammation, and amyloid deposition. Finally, the position of OPCs in drug discovery strategies for dementia is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination
Miron, V. E., Boyd, A., Zhao, J.-W., Yuen, T. J., Ruckh, J. M., Shadrach, J. L., van Wijngaarden, P., Wagers, A. J., Williams, A., Franklin, R. J. M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3469 · Cited by 1,777
Oligodendroglia metabolically support axons and contribute to neurodegeneration
Lee, Y., Morrison, B. M., Li, Y., Lengacher, S., Farah, M. H., Hoffman, P. N., Liu, Y., Tsingalia, A., Jin, L., Zhang, P.-W., et al. (2012) · Nature · doi:10.1038/nature11314 · Cited by 1,664
Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system
Marques, S., Zeisel, A., Codeluppi, S., van Bruggen, D., Mendanha Falcão, A., Xiao, L., Li, H., Häring, M., Hochgerner, H., Romanov, R. A., et al. (2016) · Science · doi:10.1126/science.aaf6463 · Cited by 1,132 · cited 1×
“The high heterogeneity between juvenile and adult OPCs and OLs populations was also confirmed by single cell RNAseq analysis [77].”
BackgroundOligodendrocytes: biology and pathology
Bradl, M., & Lassmann, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0601-5 · Cited by 933
Hughes, E. G., Kang, S. H., Fukaya, M., & Bergles, D. E. (2013) · Nature Neuroscience · doi:10.1038/nn.3390 · Cited by 808
Selective Vulnerability of Late Oligodendrocyte Progenitors to Hypoxia–Ischemia
Back, S. A., Han, B. H., Luo, N. L., Chricton, C. A., Xanthoudakis, S., Tam, J., Arvin, K. L., & Holtzman, D. M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00455.2002 · Cited by 795 · cited 1×
“Notably, the severity and the pattern of the injury mediated by HI is strictly dependent on the developmental [68] and maturation [69] stages involved.”
BackgroundWhite matter changes in Alzheimer’s disease: A focus on myelin and oligodendrocytes
Nasrabady, S. E., Rizvi, B., Goldman, J. E., & Brickman, A. M. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0515-3 · Cited by 723 · cited 2×
“In spite of the fact that, in the last years, many studies have demonstrated the involvement of WM in AD pathogenesis, the mechanism underlying these alterations, as also investigated in AD animal models, are not clear [29,30].”
BackgroundProliferation of oligodendrocyte precursor cells depends on electrical activity in axons
Barres, B. A., & Raff, M. C. (1993) · Nature · doi:10.1038/361258a0 · Cited by 673 · cited 1×
“OPCs also play an active role in activity-dependent neuronal plasticity, forming synaptic-like structures with presynaptic elements in several brain regions which contribute to activity-dependent neural plasticity [16,17], whereas presynaptic neurotransmitters bind to OPC receptors regulating OPC proliferation and dif…”
BackgroundRetinoid X receptor gamma signaling accelerates CNS remyelination
Huang, J. K., Jarjour, A. A., Nait Oumesmar, B., Kerninon, C., Williams, A., Krezel, W., Kagechika, H., Bauer, J., Zhao, C., Evercooren, A. B.-V., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2702 · Cited by 547
Regulatory T cells promote myelin regeneration in the central nervous system
Dombrowski, Y., O'Hagan, T., Dittmer, M., Penalva, R., Mayoral, S. R., Bankhead, P., Fleville, S., Eleftheriadis, G., Zhao, C., Naughton, M., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4528 · Cited by 533 · cited 1×
“thorough immune cells [47] and specific cytokines [48,49] as a response to demyelination insults.”
BackgroundOligodendrocytes and Ischemic Brain Injury
Dewar, D., Underhill, S. M., & Goldberg, M. P. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000053472.41007.f9 · Cited by 335 · cited 1×
“In particular, OLs show a low content of glutathione and low antioxidant defenses, coupled with a high consumption of oxygen and ATP, making these cells highly vulnerable to ROS production, inducing lipid peroxidation, impairing protein and nucleic acid production and promoting membrane disruption [42,72].”
BackgroundFibre-specific white matter reductions in Alzheimer’s disease and mild cognitive impairment
Mito, R., Raffelt, D., Dhollander, T., Vaughan, D. N., Tournier, J.-D., Salvado, O., Brodtmann, A., Rowe, C. C., Villemagne, V. L., & Connelly, A. (2018) · Brain · doi:10.1093/brain/awx355 · Cited by 309
Lee, J.-T., Xu, J., Lee, J.-M., Ku, G., Han, X., Yang, D.-I., Chen, S., & Hsu, C. Y. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200307017 · Cited by 280
Age- and sex-related effects on the neuroanatomy of healthy elderly
Lemaître, H., Crivello, F., Grassiot, B., Alpérovitch, A., Tzourio, C., & Mazoyer, B. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.02.042 · Cited by 280 · cited 1×
“The extensive use of MRI has shown that WM alterations in aging are numerous and extensive and different studies have identified WM atrophy [22], WM tract disruption [23], and loss of myelination [24].”
BackgroundAssociation of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease
Dean, D. C., Hurley, S. A., Kecskemeti, S. R., O’Grady, J. P., Canda, C., Davenport-Sis, N. J., Carlsson, C. M., Zetterberg, H., Blennow, K., Asthana, S., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.3232 · Cited by 252 · cited 1×
“Notably, these degenerative changes have not been associated with a high amyloid plaque burden [26,27], while other studies correlates WM pathology in preclinical AD with biomarkers in the cerebrospinal fluid [28].”
BackgroundThe Axon-Myelin Unit in Development and Degenerative Disease
Stassart, R. M., Möbius, W., Nave, K.-A., & Edgar, J. M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00467 · Cited by 246 · cited 1×
“The persistence of an appropriate myelin plasticity over the lifespan, moreover, means that axon wrapping by the OLs is modified depending on functional demand [8]: indeed the wrapping of OL cytoplasm around the axons determines the thickness of the myelin sheath and the internode length [9].”
BackgroundDesai, M. K., Mastrangelo, M. A., Ryan, D. A., Sudol, K. L., Narrow, W. C., & Bowers, W. J. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100087 · Cited by 232 · cited 1×
“This hypothesis is also confirmed by the decreased number of mature non-myelinating OLs at 6 months of age in 3 × Tg-AD [38].”
BackgroundBehrendt, G., Baer, K., Buffo, A., Curtis, M. A., Faull, R. L., Rees, M. I., Götz, M., & Dimou, L. (2013) · Glia · doi:10.1002/glia.22432 · Cited by 219
Chronic inflammation in multiple sclerosis - seeing what was always there
Matthews, P. M. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0240-y · Cited by 128 · cited 1×
“This leads to two main pathological outcomes: cell death of mature OLs, and OPC differentiation block, resulting in enhanced demyelination and remyelination impairment [52], which seems to be mediated by the alteration of the local content of triiodothyronine (T3) [53].”
BackgroundInhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death
Veto, S., Acs, P., Bauer, J., Lassmann, H., Berente, Z., Setalo, G., Borgulya, G., Sumegi, B., Komoly, S., Gallyas, F., et al. (2010) · Brain · doi:10.1093/brain/awp337 · Cited by 107
Shenkin, S. D., Bastin, M. E., MacGillivray, T. J., Deary, I. J., Starr, J. M., Rivers, C. S., & Wardlaw, J. M. (2005) · Cerebrovascular Diseases · doi:10.1159/000087930 · Cited by 92 · cited 1×
“The extensive use of MRI has shown that WM alterations in aging are numerous and extensive and different studies have identified WM atrophy [22], WM tract disruption [23], and loss of myelination [24].”
BackgroundQuintela-López, T., Ortiz-Sanz, C., Serrano-Regal, M. P., Gaminde-Blasco, A., Valero, J., Baleriola, J., Sánchez-Gómez, M. V., Matute, C., & Alberdi, E. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1636-8 · Cited by 80 · cited 1×
“Aβ oligomers also seem to contribute to OL differentiation in cultured cerebellar slices, and to enhance remyelination following lysolecithin-induced demyelination [62].”
BackgroundTse, K., Cheng, A., Ma, F., & Herrup, K. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.11.010 · Cited by 56 · cited 1×
“An emerging hypothesis suggests myelin degradation in sporadic AD as being the one of the earliest structural changes, independent of amyloid plaque formation and linked to DNA damage [71].”
Background
Cited by
Myelin in Alzheimer’s disease: culprit or bystander?
Maitre, M., Jeltsch-David, H., Okechukwu, N. G., Klein, C., Patte-Mensah, C., & Mensah-Nyagan, A.-G. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01554-5 · Cited by 66
The role of glial autophagy in Alzheimer’s disease
Litwiniuk, A., Juszczak, G. R., Stankiewicz, A. M., & Urbańska, K. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02242-5 · Cited by 54
“In the current work we strive to summarize available data on the role of autophagy in neuroglia - a crucial participant of AD pathology [6, 7].”
White matter damage in Alzheimer’s disease: contribution of oligodendrocytes
Zhou, J., Zhang, P., Zhang, B., & Kong, Y. (2022) · Current Alzheimer Research · doi:10.2174/1567205020666221021115321 · Cited by 18
“Magnetic resonance imaging (MRI) findings have shown that patients with neurodegenerative diseases, including AD, have variably high WM signals, suggesting that WM changes may play an important role in altered cognitive function [11].”
BackgroundSu, Y., Zhong, Y., Yuan, N., Li, X., Xu, Y., Yang, H., Huang, M., Zhang, Y., & Cheng, X. (2026) · Chinese Medicine · doi:10.1186/s13020-025-01284-x
Metadata
- Authors
- Lorenzini, L., Fernandez, M., Baldassarro, V. A., Bighinati, A., Giuliani, A., Calzà, L., & Giardino, L.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2020-01-23
- Volume
- 25
- Issue
- 3
- Pages
- 503
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W3002651595
- Cited by
- 29
- References
- 23
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.